Clonal Dissemination of Antifungal-Resistant Candida haemulonii, China

Emerg Infect Dis. 2023 Mar;29(3):576-584. doi: 10.3201/eid2903.221082.

Abstract

Candida haemulonii, a relative of C. auris, frequently shows antifungal resistance and is transmissible. However, molecular tools for genotyping and investigating outbreaks are not yet established. We performed genome-based population analysis on 94 C. haemulonii strains, including 58 isolates from China and 36 other published strains. Phylogenetic analysis revealed that C. haemulonii can be divided into 4 clades. Clade 1 comprised strains from China and other global strains; clades 2-4 contained only isolates from China, were more recently evolved, and showed higher antifungal resistance. Four regional epidemic clusters (A, B, C, and D) were identified in China, each comprising ≥5 cases (largest intracluster pairwise single-nucleotide polymorphism differences <50 bp). Cluster A was identified in 2 hospitals located in the same city, suggesting potential intracity transmissions. Cluster D was resistant to 3 classes of antifungals. The emergence of more resistant phylogenetic clades and regional dissemination of antifungal-resistant C. haemulonii warrants further monitoring.

Keywords: Candida haemulonii; China; antifungal resistance; antimicrobial resistance; clonal dissemination; fungi; multidrug resistance; whole-genome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents* / therapeutic use
  • Candida* / drug effects
  • Candida* / genetics
  • Candidiasis* / drug therapy
  • Candidiasis* / genetics
  • Candidiasis* / microbiology
  • China
  • Clone Cells
  • Drug Resistance, Fungal* / genetics
  • Microbial Sensitivity Tests
  • Phylogeny

Substances

  • Antifungal Agents

Supplementary concepts

  • Candida haemulonis